Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0NA5L
|
|||
| Drug Name |
AAV2-REP1
|
|||
| Indication | Choroidal dystrophy [ICD-11: 9B61; ICD-10: H31.2] | Phase 2 | [1] | |
| Company |
NightstaRx London, England
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.